Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 4 Haplotype frequencies of CDK8 in BC patients and controls

From: The role of CDK8 gene polymorphisms in bladder cancer susceptibility and prognosis: a study in the Chinese Han population

Haplotype

rs17083838

rs7992670

Controls (%)

Patients (%)

OR (95% CI)

P value

1

G

G

47.04%

53.04%

1

-

2

G

A

37.47%

37.74%

0.87(0.66–1.14)

0.31

3

A

G

9.65%

7.48%

0.73(0.45–1.19)

0.21

4

A

A

5.84%

1.74%

0.31(0.13–0.74)

0.0081

  1. All ORs and their 95% CIs are adjusted for age, sex, and smoking status; bold values denote statistically significant results (P < 0.0125). OR: odds ratio; CI: confidence interval
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us